Article
Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer.
Scientific reports - 10 Dec 2019
Schmid Virginia, Lafleur Veronique N, Lombardi Olivia, Li Ran, Salama Rafik, Colli Leandro, Choudhry Hani, Chanock Stephen, Ratcliffe Peter J, Mole David R
Abstract excerpt
Emerging evidence suggests that dysregulation of oncogenic pathways requires precise tuning in order for cancer to develop. To test this, we examined the overlap between cis-acting elements of the hypoxia-inducible factor (HIF) pathway and cancer-susceptibility polymorphisms as defined in genome-wide association studies (GWAS). In renal cancer, where HIF is constitutively and un-physiologically activated by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
